Markets
CE

DuPont, Entomol Ink License Pact for HCO Insect Repellent

DuPontDD recently signed a commercial license agreement with Entomol Products, LLC, which grants the latter the rights to make and sell products using DuPont's hydrogenated catmint oil ("HCO") technology.

DuPont HCO is a bio-based insect repellent ingredient made from the catmint (Nepeta cataria) plant which prevents insects from transmitting diseases. Management at DuPont is pleased as Entomol will bring this novel technology to the market.

Per the agreement, Entomol has been granted a commercial license related to patents, knowledge and commercial formulations of DuPont HCO for manufacturing topical HCO insect repellents. Additionally, the repellent formulation composed of HCO is registered with the U.S. Environmental Protection Agency (EPA).

Entomol has already started the production of DuPont HCO for use in a wide range of insect repellent products with distribution under private labels. Moreover, DuPont HCO comes in a topically applied formulation that has been proven effective in prevention of insects such as mosquitoes for long hours.

Shares of DuPont rose roughly 1%, to close at $67 on Nov 11.

DuPont saw its revenues and profits tumble in the third quarter of 2015 due to weak results in its agriculture business, currency headwinds and softness in emerging markets.

The company reaffirmed its adjusted earnings outlook of roughly $2.75 per share for 2015. The outlook reflects continued strengthening of the greenback versus currencies in emerging markets, mainly the Brazilian real, and softness in the agricultural markets. Unfavorable currency impact on full-year earnings is expected to be 72 cents per share.

DuPont currently carries a Zacks Rank #5 (Strong Sell).

Better-ranked stocks in the diversified chemical space include Celanese Corporation CE , Innospec Inc. IOSP and Akzo Nobel N.V. AKZOY . While Celanese and Innospec sport a Zacks Rank #1 (Strong Buy), Akzo Nobel carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DU PONT (EI) DE (DD): Free Stock Analysis Report

CELANESE CP-A (CE): Free Stock Analysis Report

AKZO NOBEL NV (AKZOY): Free Stock Analysis Report

INNOSPEC INC (IOSP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CE AKZOY IOSP

Other Topics

Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More